Institutional members access full text with Ovid®

Share this article on:

Prospective, National Clinical and Epidemiologic Study on Imported Childhood Malaria in the United Kingdom and the Republic of Ireland

Ladhani, Shamez MRCPCH*; Garbash, Mehdi MRCPCH; Whitty, Christopher J. M. FFPH‡§; Chiodini, Peter L. FRCPath, PhD‡§; Aibara, Rashna J. MRCPCH; Riordan, F. Andrew I. FRCPCH; Shingadia, Delane FRCPCH***

The Pediatric Infectious Disease Journal: May 2010 - Volume 29 - Issue 5 - p 434-438
doi: 10.1097/INF.0b013e3181c4d97c
Original Studies

Background: Current knowledge of clinical features of imported childhood malaria is largely limited to small, retrospective, and/or single-center case series. This prospective, population-based study describes the epidemiology and clinical features of imported childhood malaria in children <16 years in the United Kingdom and Republic of Ireland.

Methods: Active prospective national surveillance with clinical data collection was performed between January 1, 2006 and January 31, 2007 through the British Pediatric Surveillance Unit and capture-recapture analysis using cases reported independently to respective national surveillance centers.

Results: There were 290 cases, including 186 reported through the British Pediatric Surveillance Unit with clinical details. Capture-recapture analysis estimated the burden of imported childhood malaria to be 2.8/100,000 per year for the United Kingdom and 4.6/100,000 per year for Ireland. Black-African children born in the United Kingdom and Ireland and traveling to West Africa during school holidays without antimalarial prophylaxis accounted for the majority of cases. Thirty of 117 children (26%) who had traveled to a malaria-endemic country had previously been diagnosed with malaria, reflecting missed opportunities to educate families on malaria prevention. A third of children (46/148) with Plasmodium falciparum malaria fulfilled World Health Organization criteria for severe or potentially complicated malaria, although only 11/46 (24%) required intensive care. The choice of antimalarials varied considerably among hospitals and within the same hospital. However, recrudescence occurred in only 1 child and none died.

Conclusions: Interventions to prevent imported childhood malaria should focus on Black-African families traveling to West Africa, while pediatricians should be offered clearer guidance on the treatment of childhood malaria.


From the *Centre for Paediatrics, Institute of Cell and Molecular Science, Barts and The London School of Medicine and Dentistry, Whitechapel, London, United Kingdom; †Paediatric Infectious Diseases Department, St. George's Hospital, London, United Kingdom; ‡HPA Malaria Reference Laboratory, London School of Hygiene and Tropical Medicine, London, United Kingdom; §Hospital for Tropical Diseases, London, United Kingdom; ¶Department of Paediatrics, Central Middlesex Hospital, London, United Kingdom; ∥Department of Infectious Diseases, Alder Hey Children's NHS Foundation Trust, Liverpool, United Kingdom; and **Department of Infectious Diseases, Great Ormond Street Hospital for Children, London, United Kingdom.

Accepted for publication October 7, 2009.

Supported by the UCL Hospitals Comprehensive Biomedical Research Centre Infection Theme (to P.L.C.).

S.L. was awarded the competitive Sir Peter Tizard Research Bursary by British Pediatric Surveillance Unit (BPSU) of the Royal College of Pediatrics and Child Health to complete this study.

Any views expressed are those of the investigators and not necessarily those of the BPSU or DH.

Address for correspondence: Shamez Ladhani, MRCPCH, Centre for Paediatrics, Institute of Cell and Molecular Science, Barts and The London School of Medicine and Dentistry, The Blizard Building, 4 Newark St., Whitechapel, London E1 2AT, United Kingdom. E-mail:

Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (

© 2010 Lippincott Williams & Wilkins, Inc.